The Food and Drug Administration has issued a voluntary recall for a drug used as a local anesthetic.
According to the FDA’s website, the single dose vial of lidocaine HCI injection could have reddish-orange particulate matter floating in the solution.
The FDA says if the matter gets into a patient undergoing MRI, it could cause tissue inflammation or worse.
The vials were sold to hospitals and pharmacies in several states, including Virginia and North Carolina.
So far, Hospira, the company that makes the drug, has not reported any injuries.
